Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Gianluca Vullo
Observed names:
G Vullo,
G. Vullo,
GIANLUCA VULLO,
Vullo, Gianluca
Institution:
Azienda sanitaria universitaria Friuli Centrale
Observed institutions:
University of Udine,
Azienda Ospedaliera Sant'Andrea,
Ospedale Santa Maria della Misericordia di Udine,
Azienda sanitaria universitaria Friuli Centrale,
Sapienza University of Rome
ORCID:
0000-0002-2521-1088
Observed ORCID:
0000-0002-2521-1088
OpenAlex ID:
A5003630947
Stereotactic body radiation therapy for adrenal gland metastases: outcome and predictive factors from a multicenter analysis
2021
·
Ciro Franzese
, Luca Nicosia
, et al.
·
Clinical & Experimental Metastasis
·
23
Stereotactic Body Radiation Therapy Boost in Patients With Cervical Cancer Ineligible for Brachytherapy
2021
·
GIUSEPPE FACONDO
, GIANLUCA VULLO
, et al.
·
Cancer Diagnosis & Prognosis
·
16
Androgen Receptor Targeted Therapy + Radiotherapy in Metastatic Castration Resistant Prostate Cancer
2021
·
Maria Massaro
, Giuseppe Facondo
, et al.
·
Frontiers in Oncology
·
12
PDF
Markers of Cardiotoxicity in Early Breast Cancer Patients Treated With a Hypofractionated Schedule: A Prospective Study
2020
·
V. De Sanctis
, M. Alfò
, et al.
·
Clinical Breast Cancer
·
12
Clinical Outcomes and Toxicity of CT-guided High Dose-rate Brachytherapy in Women With Locally-advanced Cervical Cancer
2023
·
VITALIANA DE SANCTIS
, GIUSEPPE FACONDO
, et al.
·
Cancer Diagnosis & Prognosis
·
11
PDF
Stereotactic and Hypofractionated Radiotherapy Associated With Immune Checkpoint Inhibitor Drugs: Analysis of Local Control, Toxicity, and Outcome in a Single Research Centre Case Study
2021
·
DIMITRI ANZELLINI
, VITALIANA DE SANCTIS
, et al.
·
Anticancer Research
·
9
PDF
Hypofractionated Radiation Therapy (HFRT) of Breast/Chest Wall and Regional Nodes in Locally Advanced Breast Cancer: Toxicity Profile and Survival Outcomes in Retrospective Monoistitutional Study
2021
·
Sara De Matteis
, Giuseppe Facondo
, et al.
·
Clinical Breast Cancer
·
9
PDF
Image-guided moderately hypofractionated radiotherapy for localized prostate cancer: a multicentric retrospective study (IPOPROMISE)
2024
·
Gianluca Ingrosso
, Elisabetta Ponti
, et al.
·
La radiologia medica
·
8
PDF
One-week vaginal brachytherapy schedule as exclusive adjuvant post-operative treatment in intermediate- and high-intermediate-risk endometrial cancer patients
2020
·
Vitaliana De Sanctis
, Daniela Musio
, et al.
·
Journal of Contemporary Brachytherapy
·
8
PDF
Stereotactic body radiation therapy (SBRT) for patients with oligometastatic/oligoprogressive adrenal metastases: Outcomes and toxicities profile in a monoinstitutional study.
2021
·
Giuseppe Facondo
, Gianluca Vullo
, et al.
·
Cancer Treatment and Research Communications
·
6
PDF
Quality of life and sexual functioning among endometrial cancer patients treated with one week adjuvant high-dose-rate vaginal brachytherapy schedule
2022
·
Giuseppe Facondo
, Gianluca Vullo
, et al.
·
Journal of Contemporary Brachytherapy
·
5
PDF
Fiducial markers in adjuvant setting for a patient affected by endometrial cancer: a case report
2023
·
Francesca Titone
, Stefano Restaino
, et al.
·
Frontiers in Oncology
·
3
PDF
Comparative analysis of toxicity in patients with anal cancer undergoing definitive simultaneous integrated boost (SIB) or sequential integrated boost (SeqB) radiotherapy
2023
·
Margherita Rotondi
, Giuseppe Facondo
, et al.
·
International Journal of Colorectal Disease
·
3
PDF
Clinical Outcomes of Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Patients with Lymph Node Metastases from Gynecological Cancers
2023
·
Giuseppe Facondo
, Gianluca Vullo
, et al.
·
Journal of Personalized Medicine
·
3
PDF
Long-term outcomes and prognostic factors of short-course radiotherapy (SCRT) in rectal cancer: a monocentric retrospective study
2024
·
Giuseppe Facondo
, Federico Belotti
, et al.
·
Discover Oncology
·
2
PDF
Short-course Radiotherapy for Airway Stenting in Malignant Airway Obstruction: A Case Report and Literature Review
2024
·
GIUSEPPE FACONDO
, CHIARA REVERBERI
, et al.
·
Cancer Diagnosis & Prognosis
·
2
PDF
Efficacy of Residual Site Radiation Therapy (ISRT) in Patients with Primary Mediastinal Lymphoma with Deauville Score 4 Following R-CHT: Results of a Retrospective Mono Institutional Study
2023
·
Giuseppe Facondo
, Mattia Serio
, et al.
·
Journal of Clinical Medicine
·
2
PDF
Hypofractionated Radiotherapy in Intermediate-Risk Prostate Cancer Patients: Long-Term Results
2022
·
Maurizio Valeriani
, Mario Di Staso
, et al.
·
Journal of Clinical Medicine
·
2
PDF
Residual Site Radiotherapy After Immunochemotherapy in Primary Mediastinal B-Cell Lymphoma: A Monoinstitutional Retrospective Study
2020
·
VITALIANA DE SANCTIS
, ALICE DI ROCCO
, et al.
·
In Vivo
·
2
PDF
Single-Center Preliminary Experience Treating Endometrial Cancer Patients with Fiducial Markers
2025
·
Francesca Titone
, Eugenia Moretti
, et al.
·
Life
·
1
PDF
PO-1488 Local recurrence of prostate cancer after curative RT: the role of salvage SBRT re-irradiation
2023
·
R.C. Sigillo
, G. Facondo
, et al.
·
Radiotherapy and Oncology
·
1
Principles and indications of brachytherapy
2021
·
Vitaliana De Sanctis
, Giuseppe Facondo
, et al.
·
Elsevier eBooks
·
1
1415 PERSIAN TRIAL (NCT03449719): a randomized phase II trial testing Apalutamide and SBRT for hormonesensitive prostate cancer
2026
·
Giulio Francolini
, Saverio Caini
, et al.
·
Radiotherapy and Oncology
2165 Single-fraction stereotactic boost in high-risk early breast cancer: safety and early toxicity results of a phase II trial
2026
·
Giuseppe Facondo
, Agnese Prisco
, et al.
·
Radiotherapy and Oncology
PERSIAN trial (NCT03449719): Predictive features of complete biochemical response within a randomized phase II trial testing apalutamide and stereotactic body radiation therapy for low-burden, metastatic, hormone-sensitive prostate cancer.
2026
·
Giulio Francolini
, Vanessa Di Cataldo
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
42
Citation count:
141
H-index:
8
I10-index:
5
Year
Topic
Type